Study design

prospective collection and retrospective alysis

Study time

2012.1-2017.8

Country

United Kingdom

Object

53 men underwent sRARP after focal therapy

Inclusion criteria

They excluded 8 men, because including men with bilateral cancer (3 whole-gland HIFU) and ablative technologies that have dissimilar tissue effects (5 had other ablative modalities, i.e. cryotherapy or RFA) may otherwise have confounded outcomes.

Sample size

45

Topic classification

Salvage RARP，Intraoperative operation

Keypoint

Salvage RARP was safe with acceptable but sub-optimal continence and poor sexual-function and poor oncologic outcomes. One in three men required additiol treatment within 12-months.

Year